Eric Strait serves as the Executive Director of the Legal Department at Denali Therapeutics, where he plays a pivotal role in shaping the company’s legal strategy and operations. With his extensive JD/MBA background, Eric brings a unique blend of legal acumen and business insight to...
Eric Strait serves as the Executive Director of the Legal Department at Denali Therapeutics, where he plays a pivotal role in shaping the company’s legal strategy and operations. With his extensive JD/MBA background, Eric brings a unique blend of legal acumen and business insight to the biopharmaceutical industry. His leadership of the Legal Operations function encompasses critical areas such as Contracts, Paralegal, and Records Management, ensuring that Denali’s legal framework is robust and efficient.
In his current role, Eric is instrumental in overseeing Denali’s internal Development law practice, which includes managing the legal aspects of clinical trials. His close collaboration with the Regulatory and Clinical Operations teams is essential for navigating the complex regulatory landscape, ensuring compliance, and facilitating the successful progression of clinical programs. Eric’s expertise in commercial contracts and global contract negotiations enables him to develop and implement comprehensive contract templates and internal legal controls that streamline operations and mitigate risk.
Eric is also known for his strategic planning capabilities and metrics-based analysis, which drive key efficiency strategies within the legal department. His proactive approach to vendor management and full-service outsourcing has not only optimized resources but also enhanced the overall operational effectiveness of Denali Therapeutics. As a creative leader, Eric is committed to fostering a culture of collaboration and innovation, positioning Denali as a forward-thinking player in the biopharmaceutical sector. His multifaceted skill set, including contract negotiation, clinical development, and CRO management, underscores his value as a strategic partner in advancing Denali’s mission to develop transformative therapies for neurodegenerative diseases.
